Radiographic Axial Spondyloarthritis

2

Review clinical trials related to Radiographic Axial Spondyloarthritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and inflammation (swelling) in the spine and joints in the pelvis (hip bone). Radiographic means the damage it causes can be seen on X-rays. This study will help find out if a study medicine called tulisokibart can treat symptoms of r-axSpA. Researchers will look at different doses of tulisokibart. Researchers want to know if at least one of the study doses of tulisokibart works better than a placebo to improve r-axSpA symptoms. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of the study medicine.

Participants needed: 315
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Merck Sharp & Dohme LLCUpdated: Jul 13, 2026Locations: 104
Eligibility criteria

Has a clinical diagnosis of axial spondyloarthritis (axSpA) and meets the Assess... [+3]

Has any arthritis with onset before age 17 years or current diagnosis of inflamm... [+3]

Status: Recruiting

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and inflammation (swelling) in the spine and joints in the pelvis (hip bone). Radiographic means the damage it causes can be seen on X-rays. This study will help find out if a study medicine called tulisokibart can treat symptoms of r-axSpA. Researchers will look at different doses of tulisokibart. Researchers want to know if at least one of the study doses of tulisokibart works better than a placebo to improve r-axSpA symptoms. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of the study medicine.

Participants needed: 315
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Merck Sharp & Dohme LLCUpdated: Jun 29, 2026Locations: 102
Eligibility criteria

Has a clinical diagnosis of axial spondyloarthritis (axSpA) and meets the Assess... [+3]

Has any arthritis with onset before age 17 years or current diagnosis of inflamm... [+3]